Satellos Bioscience Inc.

TSX:MSCL.TO

Biotechnology

Healthcare
$8.62 +0.12%

+$0.01 today

Market cap
$182.89M
Beta
1.17
P/E (TTM)
-1.8
EPS (TTM)
-$0.32
52W Low $6.36High $18.98

Volume 0.01M

Average 0.02M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$26.92M

FY 2025 · Annual

Net Income

-$25.31M

FY 2025 · Annual

Income Statement

Mixed currencies
Metric
FY2021
Dec 2021 · CAD
FY2022
Dec 2022 · CAD
FY2023
Dec 2023 · CAD
FY2024
Dec 2024 · CAD
FY2025
Dec 2025 · USD
Revenue00000
Cost of Revenue165.69K3.73M8.82M20K5.09K
Gross Profit(165.69K)(3.73M)(8.82M)(20K)(5.09K)
Gross Margin—————
Research & Development1.88M2.59M8.82M19.6M18.75M
Selling, General & Admin2.8M5.49M6.64M8.19M7.44M
Operating Expenses4.7M4.69M15.46M27.79M26.92M
Depreciation & Amortization165.69K337K7K20K5.09K
EBITDA(4.6M)(8.09M)(15.71M)(28.08M)(26.92M)
EBITDA Margin—————
Operating Income(6.65M)(8.43M)(15.46M)(27.81M)(26.92M)
Operating Margin—————
Interest Income7.99K63K1.33M1.37M1.38M
Interest Expense985.33K0177K00
Other Income / Expenses(8.86M)(2.89M)(426K)(291K)1.79M
Income Before Tax(15.51M)(11.32M)(15.89M)(28.1M)(25.13M)
Pre-Tax Margin—————
Income Tax Expense(42.41K)5K00175.01K
Net Income(15.51M)(11.32M)(15.89M)(28.1M)(25.31M)
Net Margin—————
EPS (Basic)(7.73)(3.81)(2.21)(2.94)(1.73)
EPS (Diluted)(7.73)(3.81)(2.21)(2.94)(1.73)
Weighted Avg Shares2.01M2.97M7.2M9.56M14.6M
Weighted Avg Shares (Diluted)2.01M2.97M7.2M9.56M14.6M

MSCL.TO Earnings Waterfall · TTM

TSX:MSCL.TO · Revenue to Net Income

Key Ratios

EPS$-1.80
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-3.7
P/S Ratio0.0

Analysis

$0 of revenue converted into -$27.0M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.80, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

No filings found.

How much revenue does MSCL.TO generate?

Satellos Bioscience Inc. (MSCL.TO) reported $0.00 of revenue in fiscal 2025.

Is MSCL.TO profitable?

Satellos Bioscience Inc. (MSCL.TO) reported -$25.31M of net income.